Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Radiother Oncol. 2015 Jun 26;116(3):504–509. doi: 10.1016/j.radonc.2015.06.015

Figure 3. Dose-dependent effect of 131I-CLR1404 on HNC xenograft tumor growth inhibition.

Figure 3

Dose response profile for 131I-labeled CLR1404 (single administration) in SCC-1483 HNC tumor xenograft model confirms dose-dependent tumor growth inhibition. Differences in mean tumor size between groups reach significance by one way ANOVA on day 40 (p < 0.05) (indicated by *) but not thereafter due to loss of several animals and variance within groups.